ALT Annual Shareholders Equity
$194.10 M
+$8.81 M+4.75%
31 December 2023
Summary:
As of January 23, 2025, ALT annual stockholders equity is $194.10 million, with the most recent change of +$8.81 million (+4.75%) on December 31, 2023. During the last 3 years, it has fallen by -$31.78 million (-14.07%). ALT annual shareholders equity is now -14.07% below its all-time high of $225.88 million, reached on December 31, 2020.ALT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Quarterly Shareholders Equity
$133.38 M
-$19.15 M-12.56%
30 September 2024
Summary:
As of January 23, 2025, ALT quarterly stockholders equity is $133.38 million, with the most recent change of -$19.15 million (-12.56%) on September 30, 2024. Over the past year, it has dropped by -$60.72 million (-31.28%). ALT quarterly shareholders equity is now -45.88% below its all-time high of $246.44 million, reached on March 31, 2021.ALT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.8% | -31.3% |
| 3 y3 years | -14.1% | -36.3% |
| 5 y5 years | +301.8% | +170.1% |
ALT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.5% | +4.8% | -35.0% | at low |
| 5 y | 5-year | -14.1% | +326.4% | -45.9% | +218.3% |
| alltime | all time | -14.1% | +4515.5% | -45.9% | +1269.2% |
Altimmune Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $133.38 M(-12.6%) |
| June 2024 | - | $152.53 M(-11.8%) |
| Mar 2024 | - | $172.94 M(-10.9%) |
| Dec 2023 | $194.10 M(+4.8%) | $194.10 M(+29.1%) |
| Sept 2023 | - | $150.40 M(-10.3%) |
| June 2023 | - | $167.71 M(-0.0%) |
| Mar 2023 | - | $167.73 M(-9.5%) |
| Dec 2022 | $185.29 M(-7.0%) | $185.29 M(-9.6%) |
| Sept 2022 | - | $205.03 M(+5.4%) |
| June 2022 | - | $194.53 M(+5.2%) |
| Mar 2022 | - | $184.87 M(-7.2%) |
| Dec 2021 | $199.13 M(-11.8%) | $199.13 M(-4.8%) |
| Sept 2021 | - | $209.26 M(-13.3%) |
| June 2021 | - | $241.28 M(-2.1%) |
| Mar 2021 | - | $246.44 M(+9.1%) |
| Dec 2020 | $225.88 M(+396.2%) | $225.88 M(+13.1%) |
| Sept 2020 | - | $199.71 M(+151.1%) |
| June 2020 | - | $79.52 M(+89.8%) |
| Mar 2020 | - | $41.90 M(-8.0%) |
| Dec 2019 | $45.52 M(-5.8%) | $45.52 M(-7.8%) |
| Sept 2019 | - | $49.38 M(-12.2%) |
| June 2019 | - | $56.23 M(-5.2%) |
| Mar 2019 | - | $59.32 M(+22.8%) |
| Dec 2018 | $48.31 M(-0.7%) | $48.31 M(+21.7%) |
| Sept 2018 | - | $39.68 M(+9.3%) |
| June 2018 | - | $36.32 M(-21.9%) |
| Mar 2018 | - | $46.49 M(-4.5%) |
| Dec 2017 | $48.68 M(+51.1%) | $48.68 M(-14.7%) |
| Sept 2017 | - | $57.07 M(-24.9%) |
| June 2017 | - | $75.98 M(+320.9%) |
| Mar 2017 | - | $18.05 M(-44.0%) |
| Dec 2016 | $32.21 M(+93.4%) | $32.21 M(-76.4%) |
| Sept 2016 | - | $136.38 M(+462.4%) |
| June 2016 | - | $24.25 M(+55.2%) |
| Mar 2016 | - | $15.63 M(-6.1%) |
| Dec 2015 | $16.65 M | $16.65 M(-5.8%) |
| Sept 2015 | - | $17.67 M(-3.6%) |
| June 2015 | - | $18.34 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $20.02 M(+9.6%) |
| Dec 2014 | $18.27 M(+149.1%) | $18.27 M(+0.9%) |
| Sept 2014 | - | $18.11 M(+66.7%) |
| June 2014 | - | $10.86 M(+30.5%) |
| Mar 2014 | - | $8.33 M(+13.5%) |
| Dec 2013 | $7.34 M(-37.2%) | $7.34 M(-35.4%) |
| Sept 2013 | - | $11.35 M(-14.1%) |
| June 2013 | - | $13.22 M(+33.0%) |
| Mar 2013 | - | $9.94 M(-14.8%) |
| Dec 2012 | $11.67 M(-26.4%) | $11.67 M(-7.0%) |
| Sept 2012 | - | $12.55 M(-7.3%) |
| June 2012 | - | $13.55 M(-1.6%) |
| Mar 2012 | - | $13.77 M(-13.1%) |
| Dec 2011 | $15.85 M(+29.8%) | $15.85 M(+9.0%) |
| Sept 2011 | - | $14.54 M(+3.3%) |
| June 2011 | - | $14.07 M(+29.9%) |
| Mar 2011 | - | $10.84 M(-11.3%) |
| Dec 2010 | $12.21 M(+287.3%) | $12.21 M(-207.0%) |
| Sept 2010 | - | -$11.41 M(+18.9%) |
| June 2010 | - | -$9.60 M(+84.3%) |
| Mar 2010 | - | -$5.21 M(-265.2%) |
| Dec 2009 | $3.15 M(-83.4%) | $3.15 M(-51.4%) |
| Sept 2009 | - | $6.49 M(-37.2%) |
| June 2009 | - | $10.33 M(-37.7%) |
| Mar 2009 | - | $16.57 M(-12.6%) |
| Dec 2008 | $18.96 M(-53.3%) | $18.96 M(+69.8%) |
| Sept 2008 | - | $11.17 M(-24.2%) |
| June 2008 | - | $14.72 M(-59.2%) |
| Mar 2008 | - | $36.12 M(-11.0%) |
| Dec 2007 | $40.57 M(-1023.0%) | $40.57 M(-7.8%) |
| Sept 2007 | - | $44.00 M(-23.4%) |
| Mar 2007 | - | $57.45 M(-1407.0%) |
| Dec 2006 | -$4.40 M(-107.8%) | -$4.40 M(-107.7%) |
| Sept 2006 | - | $56.89 M(+0.5%) |
| June 2006 | - | $56.59 M(+0.5%) |
| Mar 2006 | - | $56.30 M(+0.4%) |
| Dec 2005 | $56.10 M | $56.10 M(+0.2%) |
| Sept 2005 | - | $55.96 M(>+9900.0%) |
| June 2005 | - | $22.50 K |
FAQ
- What is Altimmune annual stockholders equity?
- What is the all time high annual shareholders equity for Altimmune?
- What is Altimmune annual shareholders equity year-on-year change?
- What is Altimmune quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Altimmune?
- What is Altimmune quarterly shareholders equity year-on-year change?
What is Altimmune annual stockholders equity?
The current annual shareholders equity of ALT is $194.10 M
What is the all time high annual shareholders equity for Altimmune?
Altimmune all-time high annual stockholders equity is $225.88 M
What is Altimmune annual shareholders equity year-on-year change?
Over the past year, ALT annual stockholders equity has changed by +$8.81 M (+4.75%)
What is Altimmune quarterly stockholders equity?
The current quarterly shareholders equity of ALT is $133.38 M
What is the all time high quarterly shareholders equity for Altimmune?
Altimmune all-time high quarterly stockholders equity is $246.44 M
What is Altimmune quarterly shareholders equity year-on-year change?
Over the past year, ALT quarterly stockholders equity has changed by -$60.72 M (-31.28%)